• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 11, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Michael Bruchas receives the Jacob P. Waletzky Award

Bioengineer by Bioengineer
November 5, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

WASHINGTON, D.C. — The Society for Neuroscience (SfN) will present the Jacob P. Waletzky Award to Michael Bruchas, PhD, of the Washington University School of Medicine, at Neuroscience 2018, SfN's annual meeting and the world's largest source of emerging news about brain science and health. The award is given to a young scientist whose independent research has led to significant conceptual and empirical contributions to the understanding of drug addiction. Recipients receive a $25,000.

"On behalf of SfN, it is my pleasure to congratulate Dr. Bruchas for his leadership in the integration of stress biology, opioid signaling, and drug abuse-related behaviors, and for his outstanding contributions to our understanding of the neural circuits responsible for addiction," SfN President Richard Huganir said.

Bruchas' studies illuminating the role of kappa-opioid receptors and signaling in stress, depression, and negative affect have been crucial to the understanding of how these systems affect behavior, especially substance use and abuse. His work has advanced the understanding of the circuitry and cell biology critical to the development of drug dependence and could help to inform the development of new treatments for addiction, depression, and anxiety.

In addition to his foundational discoveries, Bruchas has taken a leading role in introducing new techniques for the study of brain function in awake, behaving rodents, applying cutting-edge technology to explore fundamental questions in the neurobiology of addiction. He has also developed sophisticated bioengineering tools to enhance the use of optogenetic techniques, with an eye toward clinical applications. His laboratory has introduced new wireless, optofluidic methods for combining pharmacology with optogenetics. Use of the "Bruchas modification" is opening new experimental possibilities and broadening even further the potential applications of optogenetics.

###

The Society for Neuroscience (SfN) is an organization of nearly 36,000 basic scientists and clinicians who study the brain and the nervous system.

Media Contact

Lauren Wingfield
[email protected]
202-962-4000
@SfNJournals

http://www.sfn.org

http://www.sfn.org/Publications/Latest-News/2018/11/03/Michael-Bruchas-Receives-the-Jacob-P-Waletzky-Award

Share12Tweet7Share2ShareShareShare1

Related Posts

Validating PRQ2000 for Measuring Dementia Social Support

November 11, 2025

Improving Maternity Care Access to Reduce Infant Mortality Rates

November 11, 2025

Sexual Dimorphism in Hypothalamic BDNF Knockout Neurons

November 11, 2025

Estrogen Influences Reward Learning and Prediction Errors

November 11, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    316 shares
    Share 126 Tweet 79
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    208 shares
    Share 83 Tweet 52
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    140 shares
    Share 56 Tweet 35
  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1305 shares
    Share 521 Tweet 326

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Validating PRQ2000 for Measuring Dementia Social Support

Sustainable 3D Cellulose Aerogels for Solar Solutions

Neoadjuvant Chemoradiotherapy vs Chemotherapy in Rectal Cancer

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.